Macquarie Group LTD Qiagen N.V. Transaction History

Macquarie Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	BUY	$41.91 - $50.48 $175,267 - $211,107	4,182 Added 142.88%	7,109 $354,000
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $119,714 - $147,579	2,927 New	2,927 $121,000
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $4,298 - $4,977	-100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $4,628 - $5,275	100 New	100 $5,000
Q2 2019 Aug 14, 2019	SELL	$35.73 - $41.39 $1.78 Million - $2.06 Million	-49,802 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$33.78 - $40.68 $150,354 - $181,066	-4,451 Reduced 8.2%	49,802 $2.02 Million
Q4 2018 Feb 15, 2019	BUY	$32.65 - $37.95 $1.77 Million - $2.06 Million	54,253 New	54,253 $1.85 Million

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.92B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.